JQ1 compound is an inhibitor of bromodomain-containing protein 4 (BRD4), belonging to the thienotriazolodiazepine class. It is a first-in-class, potent, and selective small-molecule research compound studied for its anticancer and cardioprotective properties, as well as its roles in anti-inflammatory and anti-angiogenic activities.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing JQ1 compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Encorafenib
pharmaceutical raw material
Pyrotinib
pharmaceutical raw material
Hydroxycarbamide
pharmaceutical raw material
Sulfacetamide sodium
pharmaceutical raw material
Etizolam
pharmaceutical raw material
tert-butyl 2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]acetate
DNVXATUJJDPFDM-KRWDZBQOSA-N
CC1=C(SC2=C1C(=N[C@H](C3=NN=C(N32)C)CC(=O)OC(C)(C)C)C4=CC=C(C=C4)Cl)C
Sourcing JQ1 compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.